Thank you SGW. Very fact based response to Greeesemonkey's post. Will be interesting to see if he responds to your post. Seven case studies done by TODOS. Really seven cases out of how many people that have or had covid?
Like I stated GC missed the boat on active cases so now he moves on to long haul cases to kick the can done the road and collect his massive salary.
Notice his staunt supporters don't have any issues with his salary.
By all means don't let facts get in the way of a good deceptive narrative.
Gerald has stated in interviews and I believe on Twitter that Tollovid is only effective for 12-16 hours after a dose is taken. That's the basis of the 2 per day maintenance dosing recommended and approved by the FDA. The company has never claimed that Tollovid will prevent one from contracting Covid, only that having a 3CL protease inhibitor in your system should effectively keep the a coronavirus from replicating, and one's immune system will handle the virus. They have both FDA and FTC approval to make this claim. With 3CL protease function blocked, it's action to suppress local cellular immune response doesn't occur and the body's immune system can easily overcome the virus, assuming one doesn't already have an immunity disorder.
Paxlovid's 3CL protease inhibitor is also short-lived in the body and needs the HIV drug Ritonavir to extend the time the inhibitor remains functional (until the next dose). Tollovid's inhibitor is similarly short-lived. Gerald has stated on Twitter that it's important to have the protease inhibitor already in your system to prevent infection. In response to concerns about the cost, he has recommended not taking it if a person is going to be isolated and not in potential contact with an infected person, such as staying home on a weekend, and to start back on the normal dose a few hours prior to having potential contact. This would allow a person to extend their supply and only use it when needed.
Regarding his contracting Covid, there has never been any claims about preventing the infection. How would Tollovid accomplish this anyway, since it is only a 3CL protease inhibitor? It doesn't prevent contracting the virus, but is very effective in preventing the virus from replicating. Once he contracted the virus he took the FDA-approved 5-day dosing regimen and his body was able to easily defeat the virus.
I'm not sure how one comes to the conclusion that Tollovid is ineffective against the virus, given these facts and knowing how the inhibition functions. There are an overwhelming number of documented cases where Tollovid was taken at the initial stages of contracting the virus and resulted in full recovery in very short order. To claim otherwise is misrepresenting the facts and dismissing the overwhelming feedback by those who have contacted Covid and used Tollovid to overcome it.
Regarding the soy "ingredients" not included on the label... that's because soy is NOT an ingredient. It is a potential allergen because Tollovid is manufactured on equipment that may process products containing soy, dairy or nuts. It says this clearly on the label.
I'm sure the FTC and FDA will be very impressed with the level of scrutiny demonstrated in the claims filed, especially if something this basic is so easily missed by those making the claim.
Paxlovid is TWO compounds, not just one, and includes nirmatrelvir AND ritonavir. What is pictured is nirmatrelvir, a 3CL protease inhibitor, which, ahem, is exactly what the FDA allows Todos to put on its Tollovid label...that it is a scientifically proven 3CL protease inhibitor.
You might as well put the CBD or THC formula up as contrasted to a picture of a marijuana (hemp) plant and try to say one is BS and the other is real. The analogy is exactly the same.
Are you a big fan of Pfizer?? Why don't you track down Arthur Sackler's connection with Pfizer's "Sigmamycin". If you don't know who Arthur Sackler is, read "Empire of Pain" about oxycontin. I'll help you out:
https://www.nytimes.com › 1959/05/25 › archives › pfize... Pfizer Co., Inc., of New York of mailing deceptive advertising material for its antibiotic Sigmamycin. The company denied the Commission's complaint.
Perhaps you will be correct on your assessment of Todos, or perhaps it is a turrible company that actually has a decent product, or..........or........ but it would be nice if you broadened your perspective about malfeasance to include companies that have a proven track record of multi-billion $$ fines for false advertising (Merck would fit that profile as well.....)
News 
Market Data 
Discover 
